You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

The Use of Imatinib Mesylate (GleevecTM) in Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

ID: CED 10 Sep 2008
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
I. Walker, C.T. Kouroukis, A.E. Haynes, K. Imrie